Risk of venous thromboembolism from use of oral contraceptives containing different progestogens and oestrogen doses: Danish cohort study, 2001-9

Lidegaard, O., Nielsen, L. H., Skovlund, C. W., Skjeldestad, F. E., Lokkegaard, E.·2011·BMJ
DOI 10.1136/bmj.d6423

Cited by (607)

Items 401–500 of 607

  1. Risks of venous thromboembolism with various hormonal contraceptives.
    Gary Michael Allan, Sudha Koppula · 2012 · Europe PMC (PubMed Central)
  2. Features of treatment of polycystic ovary syndrome on the overweight background
    І. М. Капшук · 2015 · Reproductive Endocrinology
  3. Impact of the French 3rd and 4th generation pill scare in women seeking termination of pregnancy
    O. Caillot, M. Aubry, Solène Duros, L. Boyer, C. Van Valenberg, Jean Lévêque, Vincent Lavoué · 2016 · Journal of Gynecology Obstetrics and Human Reproduction
  4. Superior Mesenteric Vein Thrombosis Associated with Hormonal Contraceptive Use
    Nobuatsu KOYAMA · 2016 · Case Reports in Gastroenterology
  5. The best method of contraception for smokers (a review)
    Tatyana Yu. Pestrikova, Elena A. Yurasova, Igor V. Yurasov · 2016 · Russian Journal of Human Reproduction
  6. Kontrazeption in der Perimenopause
    K. Steffen, Anneliese Schwenkhagen, Katrin Schaudig · 2017 · Der Gynäkologe
  7. The effect of combined oral contraceptives and hormone therapy during assisted reproductive technologies on the function of the hemostatic system in non-pregnant and pregnant women
    Evgeniya V. Kirakosyan, Elena A. Sosnova · 2020 · V F Snegirev Archives of Obstetrics and Gynecology
  8. ADENDO: ACTUALIZACIÓN 27/06/2020. Consenso colombiano de atención, diagnóstico y manejo de la infección por SARS-CoV-2/COVID-19 en establecimientos de atención de la salud: Recomendaciones basadas en consenso de expertos e informadas en la evidencia ACIN-IETS. SEGUNDA EDICIÓN.
    Carlos Humberto Saavedra Trujillo · 2020 · Infectio
  9. Drospirenone Effects on the Plasminogen Activator System in Immortalized Human Endometrial Endothelial Cells
    Reem Sabouni, David F. Archer, Terry A. Jacot · 2021 · Reproductive Sciences
  10. Contraception and Cardiovascular Disease
    Jan S. Erkamp, Jerome M J Cornette · 2017 · Congenital heart disease in adolescents and adults
  11. Postpartum hormonal contraceptive use in Denmark during 1997–2021
    Søren Vinther Larsen, Anders Pretzmann Mikkelsen, Kathrine Bang Madsen, Xiaoqin Liu, Trine Munk‐Olsen, Vibe G. Frøkjær, Øjvind Lidegaard · 2025 · Sexual & Reproductive Healthcare
  12. Venous Thromboembolism Requiring Anticoagulation Following Knee Arthroscopy in a Young Woman With an Intravaginal Contraceptive Device
    Robert L. Parisien, Erik Henkelman, Ronald E. McCartney, Robert Nicoletta · 2021 · Orthopedics
  13. Contraception: A Casebook from Menarche to Menopause
    2015 · The Obstetrician & Gynaecologist
  14. The combination of ethinylestradiol/cyproterone acetate is temporarily withdrawn from the market in France. Is the measure justified?
    Nathalie Chabbert‐Buffet, Jean‐Jacques Amy · 2013 · The European Journal of Contraception & Reproductive Health Care
  15. Diagnostik und Therapie der kutanen Androgenisierung im klimakterischen Übergang sowie in der Peri- und Postmenopause: Hirsutismus und Alopezie
    F. Geisthövel · 2012 · Journal für Kardiologie (Krause & Pachernegg GmbH)
  16. Venous Thromboembolism
    Farshad Shakerian, Parham Sadeghipour, Azita H. Talasaz · 2021 · Elsevier eBooks
  17. Correction of menopausal disorders: new possibilities of menopausal hormone therapy
    L.Yu. Karakhalis · 2022 · Meditsinskiy sovet = Medical Council
  18. PCOS Patients Needs Much More than Just Pills from Doctors
    Anita Mani · 2016 · Journal of General Practice
  19. Anamnesis Checklist for Informed Oral Contraceptive Choices: A Spanish Perspective
    Josep Perelló-Capó, A. Molina, Javier Trujillo Santos, María Arqueros, Esther de la Viuda, Borja Otero García-Ramos, Dolores Pérez Jaraíz, Luis Ignacio Devesa Otero · 2025 · Women s Health Reports
  20. Douleurs pelviennes associées à l’endométriose, conseils pour la pratique clinique. Un consensus formalisé d’experts par le CNGOF & Convergences PP
    Xavier Fritel, Nathalie Chabbert‐Buffet, Thierry Brillac, Alexandre Bailleul, Sessi Acapo, Éric Bautrant, Estelle Calvarin, Michel J. Canis, Christine Chalut-Natal Morin, Martine Cornillet-Bernard et al. · 2025 · Gynécologie Obstétrique Fertilité & Sénologie
  21. Hormonal Contraception and Venous Thromboembolism Risk
    Øjvind Lidegaard · 2025 · JAMA
  22. The impact of protein S and tissue factor pathway inhibitor on coagulation, assessed with thrombin generation, in women starting combined oral contraceptives
    Jesper Strandberg, Jette Nybo, Inger Lise Gade, Søren Risom Kristensen · 2025 · Research and Practice in Thrombosis and Haemostasis
  23. Increased contact system activity three months after starting combined oral contraceptives
    Jesper Strandberg, Jette Nybo, Inger Lise Gade, Yaseelan Palarasah, Else‐Marie Bladbjerg, Søren Risom Kristensen · 2025 · Thrombosis Research
  24. Approach to the Patient with Cushing’s Syndrome: Use of Anticoagulation Therapy
    Kristina Isand, John A. H. Wass, Niki Karavitaki, Maria Fleseriu, Frederikus Albertus Klok, Alberto M. Pereira · 2025 · The Journal of Clinical Endocrinology & Metabolism
  25. Different Methods and Routes of Administration of Hormonal Contraception
    Martin Hans Birkhaeuser · 2026 · Reproductive medicine for clinicians
  26. Thrombophilia Testing in Women and Adolescent Girls—Position Paper from the Standing Committee on Women’s Health Issues of the Society for Thrombosis and Haemostasis Research (GTH)
    Birgit Linnemann, Rupert Martin Bauersachs, Frauke Bergmann, Christina Hart, Edelgard Lindhoff‐Last, Hannelore Rott, Christian Pfrepper · 2026 · Hämostaseologie
  27. Prescribed hormonal contraceptive use trends in the Estonian Biobank: A longitudinal observational study
    Jelisaveta Džigurski, Märt Möls, Kristi Läll, Hannah Currant, Mall Eltermaa, Reedik Mägi, Lili A. Milani, Triin Laisk · 2026 · PLoS Medicine
  28. Contraceptive Options for Women with Thrombophilia and Thromboembolic Disease
    Jennifer Salcedo, Aparna Sridhar, Tina Rizack · 2014 · Springer eBooks
  29. Schwangerschaft, Antikonzeptiva und Bergsteigen
    Evelyn Baumgartner · 2015 · Springer eBooks
  30. Contraception Use in Women with Hypertension
    Jennifer A. Corbelli, Eleanor Bimla Schwarz · 2014 · Springer eBooks
  31. Efficacy of Drospirenone-Containing Hormone Replacement Therapy to Reduce Vasomotor Symptoms of Menopause
    Dana A. Brown, Amy Henneman, Darshana Desai · 2013 · Pharmacy
  32. Evidencias en anticoncepción
    Mariona Nadal Llover, Montse Cols Jiménez · 2014 · FMC - Formación Médica Continuada en Atención Primaria
  33. Update in Women's Health: Evidence Published in 2012
    Megan McNamara, Judith M. E. Walsh · 2013 · Annals of Internal Medicine
  34. New frontiers in female contraception (and male condoms): 2012
    Anita L. Nelson · 2012 · Expert Opinion on Investigational Drugs
  35. Increased embolic risk from combined oral contraceptives
    Gregory B. Lim · 2011 · Nature Reviews Cardiology
  36. Postmenopausal Hormone Therapy and Blood Pressure
    Zeinab Ali Issa, Ellen W. Seely, Ghada El‐Hajj Fuleihan · 2012 · Springer eBooks
  37. Suspension de Diane35® et de ses génériques : une sur-réaction de l’ANSM non fondée au vu des connaissances médicales avérées ou acquises
    J.-M. Debarre · 2013 · Annales de Dermatologie et de Vénéréologie
  38. Anticoagulation for Proximal Deep Vein Thrombosis
    Alfred Ian Lee, Eun‐Ju Lee · 2017 · Springer eBooks
  39. A practical guide to contraception. Part 1: Contraceptive pills and vaginal rings
    Deborah J. Bateson, Caroline Harvey, Kathleen M McNamee · 2013
  40. La contraception chez les adolescents canadiens
    Giuseppina Di Meglio, Colleen Crowther, Joanne Simms · 2018 · Europe PMC (PubMed Central)
  41. Perioperative cardiovascular complications following urogynecological operations
    Michael Due Larsen, Rikke Guldberg, Gunnar Lose · 2018 · Acta Obstetricia Et Gynecologica Scandinavica
  42. Oral Contraceptive Use in Obese Adolescents: A Cautionary Tale
    Deepti Warad, Asma Javed Chattha, Vilmarie Rodriguez · 2021 · Journal of Pediatric Hematology/Oncology
  43. The role of factor V Leiden and prothrombin G20210A mutations for clotting in Sudanese women under oral contraceptive use
    Osama Atiatalla Babiker Ahmed, Fathelrahman Mahdi Hassan, Mohammed Asad, Syed Mohammed Basheeruddin Asdaq, Abdulkhaliq Jassem Alsalman, Mohammad Al Mohaini, Abdulhakeem S. Alamri, Walaa Fahad Alsanie, Majid Alhomrani, Maitham Abdullah Al Hawaj et al. · 2021 · Journal of King Saud University - Science
  44. Changes in some hemostatic variables during oral contraceptive use in young women; a pilot study
    Maria M. Jastrzebska, Paulina Wajda, Kornel Chełstowski, Elżbieta Byra, Elżbieta Sowińska­‍-Przepiera · 2015 · Diagnostyka Laboratoryjna
  45. DEGAM-Benefits
    Michael M. Kochen · 2013 · Zeitschrift für Allgemeinmedizin
  46. Case Report: Branch retinal vein occlusion following COVID-19 vaccination and SARS-CoV-2 infection while taking oral contraceptives
    Tetsuya Muto, Masaaki Sakamoto, Shigeki Machida, Shinichiro Imaizumi, Yoshinobu Hamada, Koju Kamoi · 2024 · F1000Research
  47. Update hormonelle Kontrazeption
    Maximilian B. Franz · 2024 · gynäkologie + geburtshilfe
  48. Sex Hormone Treatment for Female Children and Young Adults with Disorders Affecting Hypothalamic, Pituitary, and Ovarian Function
    Hannah Ochsner, Flurina A.M. Saner, Christa E. Flück, Gabby Atlas, Anja Wüest, Margaret Zacharin, Christoph C.S. Saner · 2024 · Hormone Research in Paediatrics
  49. Gynecologic Issues in Adolescents with Developmental Delay
    Melina L. Dendrinos, Elisabeth H. Quint · 2024 · Obstetrics and Gynecology Clinics of North America
  50. The newer contraceptive pills and venous thromboembolism risk
    Therese M Foran · 2014 · The Medical Journal of Australia
  51. Синдром поликистозных яичников. Официальное заявление Европейского общества эндокринологии
    Gerard S. Conway, Didier Dewailly, Evanthia Diamanti‐Kandarakis · 2015 · The Scientific Issues of Ternopil Volodymyr Hnatiuk National Pedagogical University Series pedagogy
  52. Clinical use of oral contraceptives
    Jeong Sook Kim, SiHyun Cho · 2017 · Journal of Korean Medical Association
  53. Kontrazeptionsbeginn in der Pubertät – wann, wie, womit?
    Bettina Böttcher · 2019 · Monatsschrift Kinderheilkunde
  54. Contraception in Systemic Lupus Erythematosus (SLE)
    Faizan Shaukat, Stephanie Keeling · 2019 · Current Treatment Options in Rheumatology
  55. National survey of confirmed thromboembolism related to female hormones in Japan
    Kazuko Sugiura, Takao Kobayashi, Toshiyuki Ojima · 2020 · Journal of obstetrics and gynaecology research
  56. Obesity and venous thromboembolism
    Julia Czuprynska, Roopen Arya · 2020 · Elsevier eBooks
  57. Hormonal Contraceptives: Communication for Risk Awareness and Informed Choice, or a Public Scare?
    Barbara J. Mintzes, Teresa Leonardo Alves · 2020 · Springer eBooks
  58. Post-PE Management
    William B. Graham, Victor F. Tapson · 2020 · Respiratory medicine
  59. “What will happen in the future?” A personal VTE journey
    Ellen O’Rourke, Shane Toolan, Anne Bedos, Alexandra Tierney, Cormac J. Jennings, Annemarie O’Neill, Fionnuala Ní Áinle, Barry Kevane · 2020 · Thrombosis Update
  60. Obésité, fertilité féminine et contraception
    Sophie Dubreuil, Cécile Ciangura, Anne Bachelot · 2021 · Elsevier eBooks
  61. Cardiometabolic risk in women with PCOS
    Enrico Carmina · 2021 · Elsevier eBooks
  62. Sexualhormone
    T. Strowitzki · 2019 · Springer eBooks
  63. Thromboembolierisiko unter kombinierten hormonellen Kontrazeptiva – aktueller Stand und Verschreibungspraxis
    Dorothea M. Wunder · 2023 · Praxis
  64. Venous thromboembolism in women : risk factors and long term follow-up
    Kristina Sonnevi · 2013 · Figshare
  65. Saviez-vous que la contraception était susceptible de sauver la vie de certaines femmes ?
    Sophie Christin‐Maître · 2013 · Gynécologie Obstétrique & Fertilité
  66. Contraception œstroprogestative et risque thrombotique : des faits cliniques aux conséquences médiatiques
    Hervé Levesque, Thomas Hanslik · 2013 · La Revue de Médecine Interne
  67. Arrêtons le jeu de massacre…
    Philippe Merviel · 2013 · Gynécologie Obstétrique & Fertilité
  68. Epidemiology and prevention of deep vein thrombosis
    Lana A. Castellucci, Philip Stephen Wells · 2014
  69. Joseph W. Goldzieher on the occasion of his 100th birtday
    Giuseppe Benagiano, Ivo A Brosens · 2019 · The European Journal of Contraception & Reproductive Health Care
  70. A possible new dawn for contraception
    Norman David Goldstuck · 2020 · South African Journal of Obstetrics and Gynaecology
  71. Lower limb immobility and venous thromboembolism risk: Investigating preventive measures
    Irene E. Braithwaite · 2016
  72. To the Editor:
    Du Soon Swee, Richard Quinton · 2020 · Menopause The Journal of The North American Menopause Society
  73. Infertility and reproductive endocrinology
    Eric J. Bieber, Joseph S. Sanfilippo, Ira Horowitz, Mahmood I. Shafi · 2015 · Cambridge University Press eBooks
  74. La maladie veineuse thromboembolique chez la femme jeune :etude descriptive des facteurs de risque sur 300 patientes
    Carole Azoulai · 2014 · HAL
  75. Chapitre 4 – Épidémiologie de la thrombose veineuse et de l'embolie pulmonaire
    Karine Lacut · 2015
  76. Comprehensive Evaluation of Safyral® 2012
    Anita L. Nelson · 2012 · Women s Health
  77. Another flawed database analysis of VTE risk and hormonal contraceptives
    Anne Szarewski, Diana Mansour · 2012 · Journal of Family Planning and Reproductive Health Care
  78. Cardiovascular Risks of Hormonal Contraceptives
    Diana B. Petitti · 2013 · Current Cardiovascular Risk Reports
  79. La pilule contraceptive en pratique
    Khiyati Younès, Jacques Buxeraud · 2012 · Actualités Pharmaceutiques
  80. UNSAFE USE OF COMBINED HORMONAL CONTRACEPTIVES POSES HEALTH RISKS FOR WOMEN WITH MEDICAL CONDITIONS
    Sharon M. Bond · 2014 · Journal of Midwifery & Women s Health
  81. Combined Oral Contraceptives and Cerebral Venous Sinus Thrombosis: 2 cases and review
    Anshuja Singla, Garima Yadav, Sneha Shree · 2015 · International Journal of Reproduction Contraception Obstetrics and Gynecology
  82. Determinants of adverse events during oral anticoagulant treatment
    Marcus M. Lind · 2012 · KTH Publication Database DiVA (KTH Royal Institute of Technology)
  83. Risk of venous thromboembolism in oral contraceptive users varies according to progestin type
    Susan Sara Jick · 2012 · Evidence-Based Nursing
  84. A 90th anniversary of AOGS and onwards
    Reynir Tómas Geirsson · 2011 · Acta Obstetricia Et Gynecologica Scandinavica
  85. Kardiovaskuläre Auswirkungen hormoneller Kontrazeption
    J. Dinger, Sirka Nitschmann · 2013 · Der Internist
  86. Commentary on hormonal contraceptive use in Ireland : trends and co‐prescribing practices
    David James Williams · 2015 · British Journal of Clinical Pharmacology
  87. Risque de thrombose sous contraceptifs oraux : pharmacovigilance au CHU de Grenoble
    Camille Jorioz · 2014 · HAL
  88. CONTRACETIVOS ORAIS E RISCO TROMBÓTICO
    Abel Salazar · 2014
  89. Unravelling the link between insulin resistance and androgen excess
    Michael O’Reilly · 2015 · University of Birmingham Institutional Research Archive (University of Birmingham)
  90. Mer blodpropp med nyere p-piller
    Erlend Hem · 2012 · Tidsskrift for Den norske legeforening
  91. From research to clinical practice: viewpoint on the problem of thrombotic risks in the use of oral and nonoral combined hormonal contraceptives
    Т. Ф Татарчук, Т. Н. Тутченко, Н. В. Яроцкая · 2014 · Reproductive Endocrinology
  92. Les pilules de 3e et 4e générations : la polémique et les nouvelles recommandations
    Sophie Jandeaux · 2015 · HAL
  93. The vascular risks associated with combined oral contraceptives
    Philip C Hannaford · 2016 · BMJ
  94. Prescribing Hormonal Contraception
    Mohamed Najimudeen · 2016 · Journal of Advances in Medicine and Medical Research
  95. Anticoncepción en la adolescencia (actualizado en enero del 2013)
    Sociedad Española de Ginecología y Obstetricia · 2014 · Progresos de Obstetricia y Ginecología
  96. Thrombotic Risk of Contraceptives and Other Hormonal Therapies
    Suman L. Sood, Barbara A. Konkle · 2013 · Elsevier eBooks
  97. Therisk of oestrogens in contraceptives
    Sven Olaf Skouby · 2013 · Cambridge University Press eBooks
  98. VTE Risk as a Guiding Factor in Oral Contraceptive Selection
    Eleanor Bimla Schwarz · 2011 · Journal watch
  99. Recurrent venous thromboembolism and abnormal uterine bleeding with anticoagulant and hormone therapy use Running head: Recurrent VTE and abnormal uterine bleeding
    Ida Martinelli, Saskia Middeldorp, Marcel M Levi, Jan Beyer, Bonno van Bellen, Henri Bounameaux, Timothy Brighton, Mila Trajanovic, Martin Gebel, Hồ Chí Minh · 2017
  100. Thromboserisiko: Östrogen ist der Bösewicht!
    Friederike Klein · 2017 · CME